A surge in the use of GLP-1 drugs is among the reasons a new report projects a calorie intake decline of 10 quadrillion in ...
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise ...
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...
A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...